| Ações de Insider | 17,960,790 shares |
Pontuação de Sentimento de Insider
A Pontuação de Sentimento de Insider encontra as empresas que estão sendo compradas por insiders corporativos.
É o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por insiders. O modelo de pontuação usa uma combinação do número líquido de insiders comprando nos últimos 90 dias, o total de ações compradas como um percentual do float, e o total de ações possuídas por insiders. A escala varia de 0 a 100, com números mais altos indicando um maior nível de acumulação em relação aos seus pares, e 50 sendo a média.
Frequência de Atualização: Diariamente
Pontuação de Sentimento dos Oficiais
A Pontuação de Sentimento de Officer encontra empresas que estão sendo compradas por Oficiais Corporativos.
Por definição, Oficiais Corporativos são Insiders Corporativos, mas, ao contrário de alguns outros Insiders (Acionistas de 10% e Membros do Conselho), os Oficiais trabalham para a empresa diariamente, e eles usam seu próprio dinheiro ao negociar. (Acionistas de 10% e Membros do Conselho muitas vezes são gestores de fundos que gerenciam o dinheiro de outras pessoas.) Como tal, as negociações de insiders feitas por Oficiais são muito mais significativas e devem ser tratadas apropriadamente.
Como a Pontuação de Sentimento dos Insiders, a Pontuação de Sentimento de Officer é o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por parte dos oficiais.
Frequência de Atualização: Diariamente
Principais Métricas de Insider
Este cartão mostra como a empresa se classifica em várias métricas internas. O percentil mostra como esta empresa se compara a outras empresas nos mercados dos EUA. Classificações mais altas são indicativas de situações melhores.
Por exemplo, geralmente aceita-se que a compra interna é um indicador positivo, portanto, empresas com mais compras internas teriam classificações mais altas do que empresas com menos compras internas (ou até mesmo venda interna).
Número Líquido de Insiders Comprando (Classificação)
N/A
Número Líquido de Insiders Comprando é o número total de insiders comprando menos o número total de insiders vendendo nos últimos 90 dias. O percentil é mostrado aqui (varia de 0 a 100%).
Percentual do Float Comprado por Insiders (Classificação)
N/A
Percentual do Float Comprado por Insiders é o número total de ações compradas por insiders menos o número total de ações vendidas por insiders nos últimos 90 dias, dividido pelo total flutuante e multiplicado por 100.
Gráfico de Negociação de Insider
Eiger BioPharmaceuticals, Inc. negociações de insiders são mostradas no seguinte gráfico. Insiders são oficiais, diretores ou investidores significativos em uma empresa. Em geral, é geralmente ilegal para insiders realizarem negociações em suas empresas com base em informações materiais, não públicas. Isso não significa que seja ilegal para eles fazerem quaisquer negociações em suas próprias empresas. No entanto, eles devem relatar todas as negociações à SEC através de um Formulário 4.
Roster de Insider e Métricas de Lucratividade
Esta tabela mostra a lista de insiders conhecidos, e é gerada automaticamente a partir de arquivamentos divulgados à SEC. Além dos nomes, título mais recente, e designação de diretor, oficial ou proprietário de 10%, fornecemos as últimas participações divulgadas. Adicionalmente, quando possível fornecemos o desempenho comercial histórico do insider. O desempenho comercial histórico é uma média ponderada do desempenho de transações reais de compra no mercado aberto feitas pelo insider. Para mais informações sobre como isso é calculado, assista este webinar no YouTube.
See our leaderboard of most profitable insider traders.
| Insider | Lucro Médio (%) | Ações Possuídas |
Ajuste de Divisão |
|---|
Report errors via our new Insider Auditing Tool
Acompanhar Históricos de Compras de Insiders - Análise de Lucro a Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra de insider não planejada, feita no mercado aberto em EIGRQ / Eiger BioPharmaceuticals, Inc.. Esta análise ajuda a entender se o insider gera consistentemente retornos anormais, e vale a pena ser seguido. Esta análise é para um ano após cada negociação, e os resultados são teóricos .
A tabela a seguir mostra as compras mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.
Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.
Acompanhar Históricos de Vendas de Insiders - Análise de Perda a Curto Prazo
Nesta seção, analisamos a evitação de perda de curto prazo de cada venda de insider não planejada, feita no mercado aberto em EIGRQ / Eiger BioPharmaceuticals, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações de venda futuras possam prever quedas no preço. Esta análise é para um ano após cada negociação, e os resultados são teóricos .
A tabela a seguir mostra as vendas mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.
Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.
Histórico de Transações
Clique no ícone de link para ver o histórico completo de transações. As transações relatadas como parte de um plano de negociação automática 10b5-1 terão um X na coluna marcada como 10b-5.
| Arquivo Data |
Data da Operação |
Formulário | Insider | Ticker | Título de Segurança | Código | Direto | Preço de Exercício Preço Unitário |
Preço por Unidade |
Unidades Alteradas |
Valor Alterado (1K) |
Opções Restantes |
Ações Restantes |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-02 | 2023-11-02 | 4 | KAYNE RICHARD A See footnote. | EIGR | Common Stock | I | 0.2977 | 23,398 | 7 | 5,375,225 | ||||
| 2023-11-02 | 2023-11-01 | 4 | KAYNE RICHARD A See footnote. | EIGR | Common Stock | I | 0.2797 | 100,000 | 28 | 5,351,827 | ||||
| 2023-11-02 | 2023-10-31 | 4 | KAYNE RICHARD A See footnote. | EIGR | Common Stock | I | 0.2414 | 130,509 | 32 | 5,251,827 | ||||
| 2023-11-02 | 2023-10-31 | 4 | KAYNE RICHARD A See footnote. | EIGR | Common Stock | I | 0.2615 | 12,345 | 3 | 5,121,318 | ||||
| 2023-11-02 | 2023-10-31 | 4 | KAYNE RICHARD A See footnote. | EIGR | Common Stock | I | 0.2625 | 11,987 | 3 | 5,108,973 | ||||
| 2023-11-02 | 2023-10-31 | 4 | KAWAS LEEN See footnote. | EIGR | Common Stock | I | 0.2615 | 12,345 | 3 | 4,391,432 | ||||
| 2023-11-02 | 2023-10-31 | 4 | KAWAS LEEN See footnote. | EIGR | Common Stock | I | 0.2625 | 11,987 | 3 | 4,379,087 | ||||
| 2023-10-30 | 3 | KAYNE RICHARD A See footnote. | EIGR | Common Stock | I | 1,667,100 | ||||||||
| 2023-10-30 | 3 | KAYNE RICHARD A See footnote. | EIGR | Common Stock | I | 2,700,000 | ||||||||
| 2023-10-30 | 3 | KAYNE RICHARD A See footnote. | EIGR | Common Stock | I | 729,886 | ||||||||
| 2023-10-30 | 3 | KAWAS LEEN | EIGR | Common Stock | I | 1,667,100 | ||||||||
| 2023-10-30 | 3 | KAWAS LEEN | EIGR | Common Stock | I | 2,700,000 | ||||||||
| 2023-09-05 | 3 | Choong Ingrid By Family Trust | EIGR | Common Stock | I | 2,400 | ||||||||
| 2023-09-05 | 3 | Choong Ingrid | EIGR | Common Stock | D | 31,100 | ||||||||
| 2023-03-21 | 2023-03-17 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 1.0707 | -1,875 | -2 | 56,073 | ||||
| 2023-03-21 | 2023-03-17 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 1.0700 | -2,520 | -3 | 57,948 | ||||
| 2023-01-25 | 2023-01-23 | 4 | Dietz Thomas John By Trust | EIGR | Common Stock | I | 1.4316 | 50,000 | 72 | 50,000 | ||||
| 2023-01-03 | 2022-12-29 | 4 | Murray Christine | EIGR | Common Stock | D | 1.2208 | -5,000 | -6 | 11,000 | ||||
| 2022-12-27 | 2022-12-22 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 1.1690 | -22,500 | -26 | 21,000 | ||||
| 2022-12-27 | 2022-12-22 | 4 | Glenn Jeffrey S | EIGR | Common Stock | D | 1.2795 | 100,000 | 128 | 182,355 | ||||
| 2022-08-18 | 2022-08-16 | 4 | Apelian David | EIGR | Common Stock | D | 9.8061 | -5,000 | -49 | 11,000 | ||||
| 2022-03-14 | 2022-03-14 | 4 | Ryali Sriram | EIGR | Common Stock | D | 5.5973 | -2,266 | -13 | 41,566 | ||||
| 2022-03-14 | 2022-03-14 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 5.5973 | -1,657 | -9 | 60,468 | ||||
| 2022-03-11 | 2022-03-11 | 4 | Loh Evan | EIGR | Stock Option (Right to Buy) | D | 5.10 | 12,000 | 12,000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Loh Evan | EIGR | Common Stock | D | 6,000 | 14,000 | ||||||
| 2022-03-11 | 2022-03-11 | 4 | Atkisson Erik | EIGR | Stock Option (Right to Buy) | D | 5.10 | 38,000 | 38,000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Atkisson Erik | EIGR | Common Stock | D | 6,000 | 6,000 | ||||||
| 2022-03-11 | 2022-03-11 | 4 | Mayer Eldon C. III | EIGR | Stock Option (Right to Buy) | D | 5.10 | 98,000 | 98,000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 16,000 | 62,125 | ||||||
| 2022-03-11 | 2022-03-11 | 4 | Apelian David | EIGR | Stock Option (Right to Buy) | D | 5.10 | 12,000 | 12,000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Apelian David | EIGR | Common Stock | D | 6,000 | 16,000 | ||||||
| 2022-03-11 | 2022-03-11 | 4 | Sablich Kim | EIGR | Stock Option (Right to Buy) | D | 5.10 | 12,000 | 12,000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Sablich Kim | EIGR | Common Stock | D | 6,000 | 6,000 | ||||||
| 2022-03-11 | 2022-03-11 | 4 | Ryali Sriram | EIGR | Stock Option (Right to Buy) | D | 5.10 | 143,000 | 143,000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Ryali Sriram | EIGR | Common Stock | D | 24,000 | 43,832 | ||||||
| 2022-03-11 | 2022-03-11 | 4 | Glenn Jeffrey S | EIGR | Stock Option (Right to Buy) | D | 5.10 | 12,000 | 12,000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Glenn Jeffrey S | EIGR | Common Stock | D | 6,000 | 82,355 | ||||||
| 2022-03-11 | 2022-03-11 | 4 | Dietz Thomas John | EIGR | Stock Option (Right to Buy) | D | 5.10 | 24,000 | 24,000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 6,000 | 43,500 | ||||||
| 2022-03-11 | 2022-03-11 | 4 | Sachdev Amit | EIGR | Stock Option (Right to Buy) | D | 5.10 | 12,000 | 12,000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Sachdev Amit | EIGR | Common Stock | D | 6,000 | 16,000 | ||||||
| 2022-03-11 | 2022-03-11 | 4 | Murray Christine | EIGR | Stock Option (Right to Buy) | D | 5.10 | 12,000 | 12,000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Murray Christine | EIGR | Common Stock | D | 6,000 | 16,000 | ||||||
| 2022-03-11 | 2022-03-11 | 4 | Cory David A | EIGR | Stock Option (Right to Buy) | D | 5.10 | 281,000 | 281,000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Cory David A | EIGR | Common Stock | D | 47,000 | 169,183 | ||||||
| 2022-01-11 | 2022-01-07 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 4.9501 | -1,560 | -8 | 46,125 | ||||
| 2021-10-01 | 2021-09-30 | 4 | Atkisson Erik | EIGR | Stock Option (Right to Buy) | D | 6.68 | 180,000 | 180,000 | |||||
| 2021-07-30 | 2021-07-29 | 4 | Mayer Eldon C. III | EIGR | Stock Option (Right to Buy) | D | 8.15 | 17,500 | 17,500 | |||||
| 2021-07-30 | 2021-07-29 | 4 | Cory David A | EIGR | Stock Option (Right to Buy) | D | 8.15 | 48,750 | 48,750 | |||||
| 2021-07-30 | 2021-07-29 | 4 | Ryali Sriram | EIGR | Stock Option (Right to Buy) | D | 8.15 | 30,000 | 30,000 | |||||
| 2021-05-11 | 2021-05-10 | 4 | Ryali Sriram | EIGR | Stock Option (Right to Buy) | D | 8.49 | 87,000 | 87,000 | |||||
| 2021-04-23 | 2021-04-23 | 4 | Sablich Kim | EIGR | Stock Option (right to buy) | D | 8.43 | 25,000 | 25,000 | |||||
| 2021-04-12 | 2021-04-09 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 8.5000 | 1,000 | 8 | 37,500 | ||||
| 2021-04-12 | 2021-04-09 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 8.4800 | 1,500 | 13 | 36,500 | ||||
| 2021-03-15 | 2021-03-12 | 4 | Shaffer James P | EIGR | Stock Option (Right to Buy) | D | 9.99 | 71,250 | 71,250 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Shaffer James P | EIGR | Common Stock | D | 11,875 | 29,296 | ||||||
| 2021-03-15 | 2021-03-12 | 4 | Sachdev Amit | EIGR | Stock Option (Right to Buy) | D | 9.99 | 10,000 | 10,000 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Sachdev Amit | EIGR | Common Stock | D | 5,000 | 10,000 | ||||||
| 2021-03-15 | 2021-03-12 | 4 | Ryali Sriram | EIGR | Stock Option (Right to Buy) | D | 9.99 | 97,500 | 97,500 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Ryali Sriram | EIGR | Common Stock | D | 16,250 | 18,152 | ||||||
| 2021-03-15 | 2021-03-12 | 4 | Patton Stephana Eilene | EIGR | Stock Option (Right to Buy) | D | 9.99 | 71,250 | 71,250 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Patton Stephana Eilene | EIGR | Common Stock | D | 11,875 | 17,948 | ||||||
| 2021-03-15 | 2021-03-12 | 4 | Murray Christine | EIGR | Stock Option (Right to Buy) | D | 9.99 | 10,000 | 10,000 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Murray Christine | EIGR | Common Stock | D | 5,000 | 10,000 | ||||||
| 2021-03-15 | 2021-03-12 | 4 | Mayer Eldon C. III | EIGR | Stock Option (Right to Buy) | D | 9.99 | 71,250 | 71,250 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 11,875 | 47,685 | ||||||
| 2021-03-15 | 2021-03-15 | 4 | Loh Evan | EIGR | Common Stock | D | 10.1400 | -2,000 | -20 | 8,000 | ||||
| 2021-03-15 | 2021-03-12 | 4 | Loh Evan | EIGR | Stock Option (Right to Buy) | D | 9.99 | 10,000 | 10,000 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Loh Evan | EIGR | Common Stock | D | 5,000 | 10,000 | ||||||
| 2021-03-15 | 2021-03-12 | 4 | Glenn Jeffrey S | EIGR | Stock Option (Right to Buy) | D | 9.99 | 10,000 | 10,000 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Glenn Jeffrey S | EIGR | Common Stock | D | 5,000 | 76,355 | ||||||
| 2021-03-15 | 2021-03-12 | 4 | Dietz Thomas John | EIGR | Stock Option (Right to Buy) | D | 9.99 | 20,000 | 20,000 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 5,000 | 35,000 | ||||||
| 2021-03-15 | 2021-03-12 | 4 | Cory David A | EIGR | Stock Option (Right to Buy) | D | 9.99 | 281,000 | 281,000 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Cory David A | EIGR | Common Stock | D | 47,000 | 117,846 | ||||||
| 2021-03-15 | 2021-03-12 | 4 | Apelian David | EIGR | Stock Option (Right to Buy) | D | 9.99 | 10,000 | 10,000 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Apelian David | EIGR | Common Stock | D | 5,000 | 10,000 | ||||||
| 2021-01-11 | 2021-01-08 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 11.6800 | -1,690 | -20 | 35,810 | ||||
| 2020-08-12 | 2020-08-12 | 4 | Glenn Jeffrey S By spouse | EIGR | Common Stock | I | 11.4367 | 4,500 | 51 | 5,000 | ||||
| 2020-08-12 | 2020-08-12 | 4 | Glenn Jeffrey S By spouse | EIGR | Common Stock | I | 11.2750 | 500 | 6 | 500 | ||||
| 2020-08-12 | 2020-08-11 | 4 | Glenn Jeffrey S | EIGR | Common Stock | D | 11.4927 | 5,000 | 57 | 71,355 | ||||
| 2020-03-17 | 2020-03-16 | 4 | Glenn Jeffrey S | EIGR | Common Stock | D | 5.0271 | 30,000 | 151 | 66,355 | ||||
| 2020-03-17 | 2020-03-16 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 4.9500 | 1,000 | 5 | 30,000 | ||||
| 2020-03-13 | 2020-03-12 | 4 | Ryali Sriram | EIGR | Stock Option (Right to Buy) | D | 5.60 | 65,000 | 65,000 | |||||
| 2020-03-13 | 2020-03-05 | 4 | Ryali Sriram | EIGR | Common Stock | D | 7.3100 | 229 | 2 | 1,628 | ||||
| 2020-03-13 | 2020-03-12 | 4 | Sachdev Amit | EIGR | Stock Option (Right to Buy) | D | 5.60 | 10,000 | 10,000 | |||||
| 2020-03-13 | 2020-03-12 | 4 | Sachdev Amit | EIGR | Common Stock | D | 5,000 | 5,000 | ||||||
| 2020-03-13 | 2020-03-12 | 4 | Shaffer James P | EIGR | Stock Option (Right to Buy) | D | 5.60 | 50,000 | 50,000 | |||||
| 2020-03-13 | 2020-03-05 | 4 | Shaffer James P | EIGR | Common Stock | D | 7.3100 | 1,500 | 11 | 15,921 | ||||
| 2020-03-13 | 2020-03-12 | 4 | Loh Evan | EIGR | Stock Option (Right to Buy) | D | 5.60 | 10,000 | 10,000 | |||||
| 2020-03-13 | 2020-03-12 | 4 | Loh Evan | EIGR | Common Stock | D | 5,000 | 5,000 | ||||||
| 2020-03-13 | 2020-03-12 | 4 | Murray Christine | EIGR | Stock Option (Right to Buy) | D | 5.60 | 10,000 | 10,000 | |||||
| 2020-03-13 | 2020-03-12 | 4 | Murray Christine | EIGR | Common Stock | D | 5,000 | 5,000 | ||||||
| 2020-03-13 | 2020-03-12 | 4 | Patton Stephana Eilene | EIGR | Stock Option (Right to Buy) | D | 5.60 | 65,000 | 65,000 | |||||
| 2020-03-13 | 2020-03-05 | 4 | Patton Stephana Eilene | EIGR | Common Stock | D | 7.3100 | 820 | 6 | 4,820 | ||||
| 2020-03-13 | 2020-03-12 | 4 | Apelian David | EIGR | Stock Option (Right to Buy) | D | 5.60 | 10,000 | 10,000 | |||||
| 2020-03-13 | 2020-03-12 | 4 | Apelian David | EIGR | Common Stock | D | 5,000 | 5,000 | ||||||
| 2020-03-13 | 2020-03-12 | 4 | Dietz Thomas John | EIGR | Stock Option (Right to Buy) | D | 5.60 | 20,000 | 20,000 | |||||
| 2020-03-13 | 2020-03-12 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 5,000 | 29,000 | ||||||
| 2020-03-13 | 2020-03-12 | 4 | Cory David A | EIGR | Stock Option (Right to Buy) | D | 5.60 | 230,000 | 230,000 | |||||
| 2020-03-13 | 2020-03-05 | 4 | Cory David A | EIGR | Common Stock | D | 7.3100 | 1,500 | 11 | 69,346 | ||||
| 2020-03-13 | 2020-03-12 | 4 | Glenn Jeffrey S | EIGR | Stock Option (Right to Buy) | D | 5.60 | 10,000 | 10,000 | |||||
| 2020-03-13 | 2020-03-12 | 4 | Glenn Jeffrey S | EIGR | Common Stock | D | 5,000 | 36,355 | ||||||
| 2020-01-31 | 2020-01-31 | 4 | Mayer Eldon C. III | EIGR | Stock Option ( Right to Buy) | D | 12.36 | 150,000 | 150,000 | |||||
| 2020-01-31 | 2020-01-31 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 7,500 | 37,500 | ||||||
| 2020-01-30 | 2020-01-24 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 13.5205 | 5,000 | 68 | 30,000 | ||||
| 2020-01-13 | 2020-01-10 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 13.9400 | 4,000 | 56 | 24,000 | ||||
| 2019-09-06 | 2019-09-05 | 4 | Shaffer James P | EIGR | Common Stock | D | 7.9475 | 1,500 | 12 | 14,421 | ||||
| 2019-09-06 | 2019-09-05 | 4 | Cory David A | EIGR | Common Stock | D | 7.9475 | 1,500 | 12 | 67,846 | ||||
| 2019-09-06 | 2019-09-05 | 4 | Ryali Sriram | EIGR | Common Stock | D | 9.3670 | 149 | 1 | 1,399 | ||||
| 2019-05-30 | 2019-05-30 | 4 | Sachdev Amit | EIGR | Stock Option ( Right to Buy) | D | 11.13 | 25,000 | 25,000 | |||||
| 2019-04-26 | 2019-02-04 | 4 | Cory David A | EIGR | Common Stock | D | 11.2600 | 343 | 4 | 66,346 | ||||
| 2019-04-23 | 2019-04-23 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 11.0990 | 5,000 | 55 | 20,000 | ||||
| 2019-04-22 | 2019-04-22 | 4 | Patton Stephana Eilene | EIGR | Common Stock | D | 11.0300 | 1,000 | 11 | 4,000 | ||||
| 2019-04-22 | 2019-04-22 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 11.0500 | 5,000 | 55 | 15,000 | ||||
| 2019-04-22 | 2019-04-22 | 4 | Ryali Sriram | EIGR | Common Stock | D | 11.0822 | 1,250 | 14 | 1,250 | ||||
| 2019-03-26 | 2019-03-21 | 4 | Apelian David | EIGR | Stock Option ( Right to Buy) | D | 14.31 | 110,500 | 110,500 | |||||
| 2019-03-26 | 2019-03-21 | 4 | Shaffer James P | EIGR | Stock Option ( Right to Buy) | D | 14.31 | 50,000 | 50,000 | |||||
| 2019-03-26 | 2019-03-05 | 4 | Shaffer James P | EIGR | Common Stock | D | 7.9475 | 1,500 | 12 | 12,921 | ||||
| 2019-03-26 | 2018-09-05 | 4 | Shaffer James P | EIGR | Common Stock | D | 7.9475 | 1,500 | 12 | 11,421 | ||||
| 2019-03-26 | 2018-03-05 | 4 | Shaffer James P | EIGR | Common Stock | D | 8.0325 | 1,500 | 12 | 9,921 | ||||
| 2019-03-26 | 2017-09-05 | 4 | Shaffer James P | EIGR | Common Stock | D | 9.9025 | 1,500 | 15 | 8,421 | ||||
| 2019-03-26 | 2017-03-06 | 4 | Shaffer James P | EIGR | Common Stock | D | 8.2025 | 1,301 | 11 | 6,921 | ||||
| 2019-03-26 | 2019-03-21 | 4 | Murray Christine | EIGR | Stock Option ( Right to Buy) | D | 13.41 | 10,000 | 10,000 | |||||
| 2019-03-26 | 2019-03-21 | 4 | Cory David A | EIGR | Stock Option ( Right to Buy) | D | 14.31 | 200,000 | 200,000 | |||||
| 2019-03-26 | 2019-03-05 | 4 | Cory David A | EIGR | Common Stock | D | 7.9475 | 1,500 | 12 | 66,003 | ||||
| 2019-03-26 | 2018-09-05 | 4 | Cory David A | EIGR | Common Stock | D | 7.9475 | 1,500 | 12 | 64,503 | ||||
| 2019-03-26 | 2018-03-05 | 4 | Cory David A | EIGR | Common Stock | D | 8.0325 | 1,500 | 12 | 63,003 | ||||
| 2019-03-26 | 2017-09-05 | 4 | Cory David A | EIGR | Common Stock | D | 9.9025 | 1,500 | 15 | 61,503 | ||||
| 2019-03-26 | 2017-03-06 | 4 | Cory David A | EIGR | Common Stock | D | 8.2025 | 1,325 | 11 | 60,003 | ||||
| 2019-03-25 | 2019-03-21 | 4 | Loh Evan | EIGR | Stock Option ( Right to Buy) | D | 14.31 | 10,000 | 10,000 | |||||
| 2019-03-25 | 2019-03-21 | 4 | Glenn Jeffrey S | EIGR | Stock Option ( Right to Buy) | D | 14.31 | 10,000 | 10,000 | |||||
| 2019-03-25 | 2019-03-21 | 4 | Dietz Thomas John | EIGR | Stock Option ( Right to Buy) | D | 13.41 | 20,000 | 20,000 | |||||
| 2019-03-25 | 2019-03-21 | 4 | Mayer Eldon C. III | EIGR | Stock Option ( Right to Buy) | D | 13.41 | 10,000 | 10,000 | |||||
| 2019-03-25 | 3 | Patton Stephana Eilene | EIGR | Common Stock | D | 6,000 | ||||||||
| 2019-03-25 | 3 | Patton Stephana Eilene | EIGR | Common Stock | D | 6,000 | ||||||||
| 2019-03-25 | 3 | Patton Stephana Eilene | EIGR | Common Stock | D | 6,000 | ||||||||
| 2019-03-25 | 2019-03-21 | 4 | Patton Stephana Eilene | EIGR | Stock Option ( Right to Buy) | D | 14.31 | 90,000 | 90,000 | |||||
| 2019-02-06 | 2019-02-04 | 4 | Cory David A | EIGR | Common Stock | D | 14.1300 | 227 | 3 | 58,678 | ||||
| 2019-01-09 | 2019-01-07 | 4 | Murray Christine | EIGR | Stock Option ( Right to Buy) | D | 12.00 | 25,000 | 25,000 | |||||
| 2019-01-04 | 2019-01-03 | 4 | Ryali Sriram | EIGR | Stock Option ( Right to Buy) | D | 10.46 | 90,000 | 90,000 | |||||
| 2018-12-20 | 2018-12-20 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 9.9800 | 5,000 | 50 | 10,000 | ||||
| 2018-12-10 | 2018-12-06 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 11.2600 | 5,000 | 56 | 5,000 | ||||
| 2018-11-30 | 2018-11-29 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 10.2100 | 4,000 | 41 | 25,000 | ||||
| 2018-11-28 | 2018-11-27 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 9.9210 | 7,500 | 74 | 15,000 | ||||
| 2018-11-28 | 2018-11-26 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 9.7524 | 7,500 | 73 | 7,500 | ||||
| 2018-11-28 | 2001-11-28 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 10.0745 | 6,000 | 60 | 21,000 | ||||
| 2018-10-25 | 3 | RA Capital Healthcare Fund LP | EIGR | Common Stock | I | 4,830,916 | ||||||||
| 2018-10-25 | 3 | RA Capital Healthcare Fund LP | EIGR | Common Stock | I | 4,830,916 | ||||||||
| 2018-10-25 | 3 | RA Capital Healthcare Fund LP | EIGR | Common Stock | I | 4,830,916 | ||||||||
| 2018-10-25 | 3 | RA Capital Healthcare Fund LP | EIGR | Common Stock | I | 4,830,916 | ||||||||
| 2018-10-25 | 3 | RA Capital Healthcare Fund LP | EIGR | Common Stock | I | 4,830,916 | ||||||||
| 2018-10-22 | 2018-10-18 | 4 | INTERWEST PARTNERS X LP | EIGR | Common Stock | D | 12.0010 | -26,465 | -318 | 1,362,327 | ||||
| 2018-10-22 | 2018-10-18 | 4 | INTERWEST PARTNERS X LP | EIGR | Common Stock | D | 12.0717 | -210,800 | -2,545 | 1,388,792 | ||||
| 2018-04-04 | 2018-04-02 | 4 | Quan Joanne | EIGR | Stock Option (Right to Buy) | D | 2.06 | -4,000 | 22,256 | |||||
| 2018-04-04 | 2018-04-02 | 4 | Quan Joanne | EIGR | Common Stock | D | 10.0000 | -4,000 | -40 | 0 | ||||
| 2018-04-04 | 2018-04-02 | 4 | Quan Joanne | EIGR | Common Stock | D | 2.0600 | 4,000 | 8 | 4,000 | ||||
| 2018-03-16 | 2018-03-14 | 4 | Cory David A | EIGR | Stock Option (Right to Buy) | D | 9.50 | 190,000 | 190,000 | |||||
| 2018-03-16 | 2018-03-14 | 4 | Apelian David | EIGR | Stock Option (Right to Buy) | D | 9.50 | 37,000 | 37,000 | |||||
| 2018-03-16 | 2018-03-14 | 4 | Dietz Thomas John | EIGR | Stock Option (Right to Buy) | D | 9.50 | 10,000 | 10,000 | |||||
| 2018-03-16 | 2018-03-14 | 4 | Mayer Eldon C. III | EIGR | Stock Option (Right to Buy) | D | 9.50 | 10,000 | 10,000 | |||||
| 2018-03-16 | 2018-03-14 | 4 | Loh Evan | EIGR | Stock Option (Right to Buy) | D | 9.50 | 10,000 | 10,000 | |||||
| 2018-03-16 | 2018-03-14 | 4 | Glenn Jeffrey S | EIGR | Stock Option (Right to Buy) | D | 9.50 | 10,000 | 10,000 | |||||
| 2018-03-16 | 2018-03-14 | 4 | WELCH JAMES H | EIGR | Stock Option (Right to Buy) | D | 9.50 | 60,000 | 60,000 | |||||
| 2018-03-16 | 2018-03-14 | 4 | Quan Joanne | EIGR | Stock Option (Right to Buy) | D | 9.50 | 60,000 | 60,000 | |||||
| 2018-03-16 | 2018-03-14 | 4 | Shaffer James P | EIGR | Stock Option (Right to Buy) | D | 9.50 | 60,000 | 60,000 | |||||
| 2018-01-09 | 2018-01-05 | 4 | Mayer Eldon C. III | EIGR | Stock Option (right to buy) | D | 13.70 | 25,000 | 25,000 | |||||
| 2018-01-09 | 2018-01-05 | 4 | Apelian David | EIGR | Stock Option (Right to Buy) | D | 13.70 | 150,000 | 150,000 | |||||
| 2017-10-06 | 2017-09-28 | 4 | Apelian David | EIGR | Stock Option (Right to Buy) | D | 10.75 | 25,000 | 25,000 | |||||
| 2017-09-18 | 2017-09-15 | 4 | Loh Evan | EIGR | Stock Option (Right to Buy) | D | 11.15 | 25,000 | 25,000 | |||||
| 2017-09-05 | 2017-09-01 | 4 | Glenn Jeffrey S | EIGR | Common Stock | D | 9.5300 | 15,000 | 143 | 31,355 | ||||
| 2017-04-14 | 2017-04-12 | 4 | Kjellson Nina S | EIGR | Stock Option (Right to Buy) | D | 8.50 | 10,000 | 10,000 | |||||
| 2017-04-13 | 2017-04-12 | 4 | Bramlage Charles | EIGR | Stock Option (Right to Buy) | D | 8.50 | 10,000 | 10,000 | |||||
| 2017-04-13 | 2017-04-12 | 4 | ENGLEMAN EDGAR | EIGR | Stock Option (Right to Buy) | D | 8.50 | 10,000 | 10,000 | |||||
| 2017-04-13 | 2017-04-12 | 4 | Glenn Jeffrey S | EIGR | Stock Option (Right to Buy) | D | 8.50 | 10,000 | 10,000 | |||||
| 2017-04-13 | 2017-04-12 | 4 | Dietz Thomas John | EIGR | Stock Option (Right to Buy) | D | 8.50 | 10,000 | 10,000 | |||||
| 2017-03-14 | 2017-03-09 | 4 | Martins Eduardo Bruno | EIGR | Stock Option (Right to Buy) | D | 11.75 | 30,000 | 30,000 | |||||
| 2017-03-14 | 2017-03-09 | 4 | Quan Joanne | EIGR | Stock Option (Right to Buy) | D | 11.75 | 30,000 | 30,000 | |||||
| 2017-03-14 | 2017-03-09 | 4 | Cory David A | EIGR | Stock Option (Right to Buy) | D | 11.75 | 133,000 | 133,000 | |||||
| 2017-03-14 | 2017-03-09 | 4 | Shaffer James P | EIGR | Stock Option (Right to Buy) | D | 11.75 | 40,000 | 40,000 | |||||
| 2017-03-14 | 2017-03-09 | 4 | WELCH JAMES H | EIGR | Stock Option (Right to Buy) | D | 11.75 | 40,000 | 40,000 | |||||
| 2016-11-21 | 2016-11-18 | 4 | Glenn Jeffrey S By son | EIGR | Common Stock | I | 12.9000 | 460 | 6 | 460 | ||||
| 2016-11-21 | 2016-11-17 | 4 | Glenn Jeffrey S | EIGR | Common Stock | D | 12.7300 | 15,000 | 191 | 16,355 | ||||
| 2016-09-15 | 2016-03-28 | 4/A | Bramlage Charles | EIGR | Stock Option (Right to Buy) | D | 15.75 | 25,000 | 25,000 | |||||
| 2016-09-15 | 2016-03-23 | 4/A | Cory David A | EIGR | Stock Option (Right to Buy) | D | 15.89 | 285,991 | 285,991 | |||||
| 2016-09-15 | 2016-03-28 | 4/A | Dietz Thomas John | EIGR | Stock Option (Right to Buy) | D | 15.75 | 23,000 | 23,000 | |||||
| 2016-09-15 | 2016-03-28 | 4/A | Dietz Thomas John | EIGR | Stock Option (Right to Buy) | D | 15.75 | 25,000 | 25,000 | |||||
| 2016-09-15 | 2016-03-28 | 4/A | Glenn Jeffrey S | EIGR | Stock Option (Right to Buy) | D | 15.75 | 30,000 | 30,000 | |||||
| 2016-09-15 | 2016-03-28 | 4/A | Glenn Jeffrey S | EIGR | Stock Option (Right to Buy) | D | 15.75 | 25,000 | 25,000 | |||||
| 2016-09-15 | 2016-03-23 | 4/A | Martins Eduardo Bruno | EIGR | Stock Option (Right to Buy) | D | 15.89 | 65,216 | 65,216 | |||||
| 2016-09-15 | 2016-03-23 | 4/A | Quan Joanne | EIGR | Stock Option (Right to Buy) | D | 15.89 | 53,452 | 53,452 | |||||
| 2016-09-15 | 2016-03-23 | 4/A | Shaffer James P | EIGR | Stock Option (Right to Buy) | D | 15.89 | 60,699 | 60,699 | |||||
| 2016-09-15 | 2016-03-23 | 4/A | WELCH JAMES H | EIGR | Stock Option (Right to Buy) | D | 15.89 | 57,571 | 57,571 | |||||
| 2016-09-15 | 2016-03-28 | 4/A | ENGLEMAN EDGAR | EIGR | Stock Option (Right to Buy) | D | 15.75 | 25,000 | 25,000 | |||||
| 2016-09-15 | 2016-03-28 | 4/A | Kjellson Nina S | EIGR | Stock Option (Right to Buy) | D | 15.75 | 25,000 | 25,000 | |||||
| 2016-08-22 | 2016-08-18 | 4 | Vivo Ventures VI, LLC By Vivo Ventures VI Affiliates Fund, L.P. | EIGR | Common Stock | I | 16.0000 | 1,364 | 22 | 12,996 | ||||
| 2016-08-22 | 2016-08-18 | 4 | Vivo Ventures VI, LLC By Vivo Ventures Fund VI, L.P. | EIGR | Common Stock | I | 16.0000 | 186,136 | 2,978 | 1,774,096 | ||||
| 2016-08-19 | 2016-08-18 | 4 | Shaffer James P | EIGR | Common Stock | D | 15.7000 | 3,125 | 49 | 5,620 | ||||
| 2016-08-19 | 2016-08-18 | 4 | Cory David A | EIGR | Common Stock | D | 15.7000 | 1,562 | 25 | 58,451 | ||||
| 2016-06-22 | 2016-06-22 | 4 | WELCH JAMES H | EIGR | Common Stock | D | 19.7944 | 500 | 10 | 2,500 | ||||
| 2016-06-22 | 2016-06-20 | 4 | WELCH JAMES H | EIGR | Common Stock | D | 19.7962 | 2,000 | 40 | 2,000 | ||||
| 2016-06-14 | 2016-06-13 | 4 | Shaffer James P | EIGR | Common Stock | D | 22.2000 | 420 | 9 | 2,495 | ||||
| 2016-06-14 | 2016-06-13 | 4 | Shaffer James P | EIGR | Common Stock | D | 22.1700 | 100 | 2 | 2,075 | ||||
| 2016-06-14 | 2016-06-13 | 4 | Shaffer James P | EIGR | Common Stock | D | 22.1600 | 730 | 16 | 1,975 | ||||
| 2016-05-23 | 2016-05-23 | 4 | Shaffer James P | EIGR | Common Stock | D | 19.9900 | 745 | 15 | 1,245 | ||||
| 2016-05-23 | 2016-05-19 | 4 | Shaffer James P | EIGR | Common Stock | D | 19.5200 | 500 | 10 | 500 | ||||
| 2016-04-04 | 2016-03-28 | 4 | ENGLEMAN EDGAR | EIGR | Stock Option (Right to Buy) | D | 15.75 | 25,000 | 25,000 | |||||
| 2016-04-01 | 2016-03-28 | 4 | Bramlage Charles | EIGR | Stock Option (Right to Buy) | D | 15.75 | 25,000 | 25,000 | |||||
| 2016-04-01 | 2016-03-28 | 4 | Kjellson Nina S | EIGR | Stock Option (Right to Buy) | D | 15.75 | 25,000 | 25,000 | |||||
| 2016-04-01 | 2016-03-28 | 4 | Dietz Thomas John | EIGR | Stock Option (Right to Buy) | D | 15.75 | 23,000 | 23,000 | |||||
| 2016-04-01 | 2016-03-28 | 4 | Dietz Thomas John | EIGR | Stock Option (Right to Buy) | D | 15.75 | 25,000 | 25,000 | |||||
| 2016-04-01 | 2016-03-28 | 4 | Glenn Jeffrey S | EIGR | Stock Option (Right to Buy) | D | 15.75 | 30,000 | 30,000 | |||||
| 2016-04-01 | 2016-03-28 | 4 | Glenn Jeffrey S | EIGR | Stock Option (Right to Buy) | D | 15.75 | 25,000 | 25,000 | |||||
| 2016-03-31 | 3 | Kjellson Nina S By limited partnership | EIGR | Common Stock | I | 3,199,186 | ||||||||
| 2016-03-31 | 3 | Kjellson Nina S By limited partnership | EIGR | Common Stock | I | 3,199,186 | ||||||||
| 2016-03-31 | 3 | NASR KHALED | EIGR | Common Stock | D | 3,199,186 | ||||||||
| 2016-03-31 | 3 | NASR KHALED | EIGR | Common Stock | D | 3,199,186 | ||||||||
| 2016-03-31 | 3 | NASR KHALED | EIGR | Common Stock | D | 3,199,186 | ||||||||
| 2016-03-31 | 3 | NASR KHALED | EIGR | Common Stock | D | 3,199,186 | ||||||||
| 2016-03-31 | 3 | NASR KHALED | EIGR | Common Stock | D | 3,199,186 | ||||||||
| 2016-03-31 | 3 | NASR KHALED | EIGR | Common Stock | D | 3,199,186 | ||||||||
| 2016-03-31 | 3 | NASR KHALED | EIGR | Common Stock | D | 3,199,186 | ||||||||
| 2016-03-31 | 3 | NASR KHALED | EIGR | Common Stock | D | 3,199,186 | ||||||||
| 2016-03-31 | 3 | NASR KHALED | EIGR | Common Stock | D | 3,199,186 | ||||||||
| 2016-03-31 | 3 | NASR KHALED | EIGR | Common Stock | D | 3,199,186 | ||||||||
| 2016-03-28 | 3 | Vivo Ventures Fund VI, L.P. See footnote 2 | EIGR | Common Stock | I | 1,611,224 | ||||||||
| 2016-03-28 | 3 | Vivo Ventures Fund VI, L.P. See footnote 1 | EIGR | Common Stock | I | 3,187,552 | ||||||||
| 2016-03-28 | 3 | Vivo Ventures Fund VI, L.P. See footnote 2 | EIGR | Common Stock | I | 1,611,224 | ||||||||
| 2016-03-28 | 3 | Vivo Ventures Fund VI, L.P. See footnote 1 | EIGR | Common Stock | I | 3,187,552 | ||||||||
| 2016-03-28 | 3 | Vivo Ventures Fund VI, L.P. See footnote 2 | EIGR | Common Stock | I | 1,611,224 | ||||||||
| 2016-03-28 | 3 | Vivo Ventures Fund VI, L.P. See footnote 2 | EIGR | Common Stock | I | 1,611,224 | ||||||||
| 2016-03-28 | 3 | Vivo Ventures Fund VI, L.P. See footnote 1 | EIGR | Common Stock | I | 3,187,552 | ||||||||
| 2016-03-28 | 3 | Vivo Ventures Fund VI, L.P. See footnote 1 | EIGR | Common Stock | I | 3,187,552 | ||||||||
| 2016-03-28 | 3 | Cory David A | EIGR | Common Stock | D | 144,128 | ||||||||
| 2016-03-28 | 3 | Cory David A | EIGR | Common Stock | D | 144,128 | ||||||||
| 2016-03-28 | 3 | Cory David A See footnote 1 | EIGR | Common Stock | I | 117,589 | ||||||||
| 2016-03-28 | 3 | Cory David A See footnote 1 | EIGR | Common Stock | I | 117,589 | ||||||||
| 2016-03-28 | 2016-03-23 | 4 | WELCH JAMES H | EIGR | Stock Option (Right to Buy) | D | 15.89 | 57,571 | 57,571 | |||||
| 2016-03-28 | 2016-03-23 | 4 | Shaffer James P | EIGR | Stock Option (Right to Buy) | D | 15.89 | 60,699 | 60,699 | |||||
| 2016-03-28 | 2016-03-23 | 4 | Cory David A | EIGR | Stock Option (Right to Buy) | D | 15.89 | 285,991 | 285,991 | |||||
| 2016-03-28 | 2016-03-23 | 4 | Quan Joanne | EIGR | Stock Option (Right to Buy) | D | 15.89 | 53,452 | 53,452 | |||||
| 2016-03-28 | 2016-03-23 | 4 | Martins Eduardo Bruno | EIGR | Stock Option (Right to Buy) | D | 15.89 | 65,216 | 65,216 | |||||
| 2016-03-25 | 3 | Glenn Jeffrey S | EIGR | Common Stock | I | 303,483 | ||||||||
| 2016-03-25 | 3 | Glenn Jeffrey S | EIGR | Common Stock | I | 303,483 | ||||||||
| 2016-03-25 | 3 | Glenn Jeffrey S | EIGR | Common Stock | D | 153,774 | ||||||||
| 2016-03-25 | 3 | Glenn Jeffrey S | EIGR | Common Stock | D | 153,774 | ||||||||
| 2016-03-25 | 3 | ENGLEMAN EDGAR See footnote 1 | EIGR | Common Stock | I | 3,187,552 | ||||||||
| 2016-03-25 | 3 | ENGLEMAN EDGAR See footnote 2 | EIGR | Common Stock | I | 1,611,224 | ||||||||
| 2016-03-25 | 3 | ENGLEMAN EDGAR See footnote 1 | EIGR | Common Stock | I | 3,187,552 | ||||||||
| 2016-03-25 | 3 | ENGLEMAN EDGAR See footnote 2 | EIGR | Common Stock | I | 1,611,224 | ||||||||
| 2015-06-30 | 3 | EcoR1 Capital, LLC See Note | CLDN | Common Stock | I | 5,686,340 | ||||||||
| 2015-06-30 | 3 | EcoR1 Capital, LLC See Note | CLDN | Common Stock | I | 5,686,340 | ||||||||
| 2015-06-05 | 2015-06-04 | 4 | Alton Gregg H | CLDN | Stock option (right to buy) | D | 2.16 | 10,000 | 40,000 | |||||
| 2015-06-05 | 2015-06-04 | 4 | NARACHI MICHAEL | CLDN | Stock option (right to buy) | D | 2.16 | 10,000 | 50,000 | |||||
| 2015-06-05 | 2015-06-04 | 4 | COOPER GRAHAM K | CLDN | Stock option (right to buy) | D | 2.16 | 10,000 | 40,000 | |||||
| 2015-06-05 | 2015-06-04 | 4 | Honig Peter | CLDN | Stock option (right to buy) | D | 2.16 | 10,000 | 22,800 | |||||
| 2015-04-07 | 2015-04-06 | 4 | ZSEBO KRISZTINA M | CLDN | Stock option (right to buy) | D | 8.00 | -6,629 | 645,717 | |||||
| 2015-04-07 | 2015-04-06 | 4 | ZSEBO KRISZTINA M | CLDN | Stock option (right to buy) | D | 1.12 | -41,302 | 652,346 | |||||
| 2015-04-07 | 2015-04-06 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 18.4400 | -6,629 | -122 | 3,125 | ||||
| 2015-04-07 | 2015-04-06 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 18.1600 | -41,302 | -750 | 9,754 | ||||
| 2015-04-07 | 2015-04-06 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 8.0000 | 6,629 | 53 | 51,056 | ||||
| 2015-04-07 | 2015-04-06 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 1.1200 | 41,302 | 46 | 44,427 | ||||
| 2015-04-03 | 2015-04-01 | 4 | TAKEYA RYAN K | CLDN | Stock option (right to buy) | D | 1.12 | -4,444 | 139,574 | |||||
| 2015-04-03 | 2015-04-01 | 4 | TAKEYA RYAN K | CLDN | Common Stock | D | 19.1300 | -4,444 | -85 | 1,432 | ||||
| 2015-04-03 | 2015-04-01 | 4 | TAKEYA RYAN K | CLDN | Common Stock | D | 1.1200 | 4,444 | 5 | 5,876 | ||||
| 2015-04-03 | 2015-04-02 | 4 | LABA REBECQUE J | CLDN | Stock option (right to buy) | D | 8.00 | -1,012 | 150,726 | |||||
| 2015-04-03 | 2015-04-02 | 4 | LABA REBECQUE J | CLDN | Stock option (right to buy) | D | 1.12 | -10,000 | 151,738 | |||||
| 2015-04-03 | 2015-04-02 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 16.9500 | -1,012 | -17 | 2,895 | ||||
| 2015-04-03 | 2015-04-02 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 17.3300 | -10,000 | -173 | 3,907 | ||||
| 2015-04-03 | 2015-04-02 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 8.0000 | 1,012 | 8 | 13,907 | ||||
| 2015-04-03 | 2015-04-02 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 1.1200 | 10,000 | 11 | 12,895 | ||||
| 2015-03-17 | 3 | Jackson Andrew C. | CLDN | Common Stock | D | 3,174 | ||||||||
| 2015-03-17 | 3 | Jackson Andrew C. | CLDN | Common Stock | D | 3,174 | ||||||||
| 2015-03-09 | 2015-03-09 | 4 | ZSEBO KRISZTINA M | CLDN | Stock option (right to buy) | D | 8.00 | -6,629 | 693,648 | |||||
| 2015-03-09 | 2015-03-09 | 4 | ZSEBO KRISZTINA M | CLDN | Stock option (right to buy) | D | 1.12 | -41,302 | 700,277 | |||||
| 2015-03-09 | 2015-03-09 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 24.7100 | -6,629 | -164 | 3,125 | ||||
| 2015-03-09 | 2015-03-09 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 24.8100 | -41,302 | -1,025 | 9,754 | ||||
| 2015-03-09 | 2015-03-09 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 8.0000 | 6,629 | 53 | 51,056 | ||||
| 2015-03-09 | 2015-03-09 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 1.1200 | 41,302 | 46 | 44,427 | ||||
| 2015-03-09 | 2015-03-06 | 4 | Honig Peter | CLDN | Stock option (right to buy) | D | 9.58 | -5,000 | 12,800 | |||||
| 2015-03-09 | 2015-03-06 | 4 | Honig Peter | CLDN | Common Stock | D | 25.0000 | -5,000 | -125 | 0 | ||||
| 2015-03-09 | 2015-03-06 | 4 | Honig Peter | CLDN | Common Stock | D | 9.5800 | 5,000 | 48 | 5,000 | ||||
| 2015-03-09 | 2015-03-05 | 4 | Honig Peter | CLDN | Stock option (right to buy) | D | 11.30 | -2,200 | 17,800 | |||||
| 2015-03-09 | 2015-03-05 | 4 | Honig Peter | CLDN | Stock option (right to buy) | D | 11.30 | -2,500 | 20,000 | |||||
| 2015-03-09 | 2015-03-05 | 4 | Honig Peter | CLDN | Common Stock | D | 22.2900 | -2,200 | -49 | 0 | ||||
| 2015-03-09 | 2015-03-05 | 4 | Honig Peter | CLDN | Common Stock | D | 22.5000 | -2,500 | -56 | 2,200 | ||||
| 2015-03-09 | 2015-03-05 | 4 | Honig Peter | CLDN | Common Stock | D | 11.3000 | 2,200 | 25 | 4,700 | ||||
| 2015-03-09 | 2015-03-05 | 4 | Honig Peter | CLDN | Common Stock | D | 11.3000 | 2,500 | 28 | 2,500 | ||||
| 2015-03-09 | 2015-03-06 | 4 | LABA REBECQUE J | CLDN | Stock option (right to buy) | D | 8.00 | -4,000 | 161,738 | |||||
| 2015-03-09 | 2015-03-06 | 4 | LABA REBECQUE J | CLDN | Stock option (right to buy) | D | 1.12 | -10,000 | 165,738 | |||||
| 2015-03-09 | 2015-03-06 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 22.4800 | -4,000 | -90 | 2,895 | ||||
| 2015-03-09 | 2015-03-06 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 23.2900 | -10,000 | -233 | 6,895 | ||||
| 2015-03-09 | 2015-03-06 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 8.0000 | 4,000 | 32 | 16,895 | ||||
| 2015-03-09 | 2015-03-06 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 1.1200 | 10,000 | 11 | 12,895 | ||||
| 2015-03-03 | 2015-03-02 | 4 | TAKEYA RYAN K | CLDN | Stock option (right to buy) | D | 1.12 | -7,777 | 144,018 | |||||
| 2015-03-03 | 2015-03-02 | 4 | TAKEYA RYAN K | CLDN | Common Stock | D | 18.4800 | -7,777 | -144 | 1,432 | ||||
| 2015-03-03 | 2015-03-02 | 4 | TAKEYA RYAN K | CLDN | Common Stock | D | 1.1200 | 7,777 | 9 | 9,209 | ||||
| 2015-02-10 | 2015-02-06 | 4 | LABA REBECQUE J | CLDN | Stock option (right to buy) | D | 8.00 | -4,000 | 175,738 | |||||
| 2015-02-10 | 2015-02-06 | 4 | LABA REBECQUE J | CLDN | Stock option (right to buy) | D | 1.12 | -10,000 | 179,738 | |||||
| 2015-02-10 | 2015-02-06 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 16.0800 | -4,000 | -64 | 2,895 | ||||
| 2015-02-10 | 2015-02-06 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 16.0800 | -10,000 | -161 | 6,895 | ||||
| 2015-02-10 | 2015-02-06 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 8.0000 | 4,000 | 32 | 16,895 | ||||
| 2015-02-10 | 2015-02-06 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 1.1200 | 10,000 | 11 | 12,895 | ||||
| 2015-02-10 | 2015-02-09 | 4 | ZSEBO KRISZTINA M | CLDN | Stock option (right to buy) | D | 8.00 | -6,629 | 741,579 | |||||
| 2015-02-10 | 2015-02-09 | 4 | ZSEBO KRISZTINA M | CLDN | Stock option (right to buy) | D | 1.12 | -41,302 | 748,208 | |||||
| 2015-02-10 | 2015-02-09 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 15.9400 | -6,629 | -106 | 3,125 | ||||
| 2015-02-10 | 2015-02-09 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 15.8500 | -41,302 | -655 | 9,754 | ||||
| 2015-02-10 | 2015-02-09 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 8.0000 | 6,629 | 53 | 51,056 | ||||
| 2015-02-10 | 2015-02-09 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 1.1200 | 41,302 | 46 | 44,427 | ||||
| 2015-02-03 | 2015-02-02 | 4 | TAKEYA RYAN K | CLDN | Stock option (right to buy) | D | 1.12 | -7,777 | 151,795 | |||||
| 2015-02-03 | 2015-02-02 | 4 | TAKEYA RYAN K | CLDN | Common Stock | D | 16.3500 | -7,777 | -127 | 1,432 | ||||
| 2015-02-03 | 2015-02-02 | 4 | TAKEYA RYAN K | CLDN | Common Stock | D | 1.1200 | 7,777 | 9 | 9,209 | ||||
| 2015-01-12 | 2015-01-09 | 4 | RUDY JEFFREY J | CLDN | Stock option (right to buy) | D | 1.12 | -10,000 | 181,738 | |||||
| 2015-01-12 | 2015-01-09 | 4 | RUDY JEFFREY J | CLDN | Common Stock | D | 18.5100 | -10,000 | -185 | 1,024 | ||||
| 2015-01-12 | 2015-01-09 | 4 | RUDY JEFFREY J | CLDN | Common Stock | D | 1.1200 | 10,000 | 11 | 11,024 | ||||
| 2015-01-08 | 2015-01-06 | 4 | ZSEBO KRISZTINA M | CLDN | Stock option (right to buy) | D | 1.12 | -41,302 | 789,510 | |||||
| 2015-01-08 | 2015-01-06 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 17.5100 | -41,302 | -723 | 3,125 | ||||
| 2015-01-08 | 2015-01-06 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 1.1200 | 41,302 | 46 | 44,427 | ||||
| 2015-01-08 | 2015-01-07 | 4 | LABA REBECQUE J | CLDN | Stock option (right to buy) | D | 1.12 | -20,000 | 189,738 | |||||
| 2015-01-08 | 2015-01-07 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 17.3000 | -20,000 | -346 | 2,895 | ||||
| 2015-01-08 | 2015-01-07 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 1.1200 | 20,000 | 22 | 22,895 | ||||
| 2015-01-05 | 2015-01-02 | 4 | TAKEYA RYAN K | CLDN | Stock option (right to buy) | D | 1.12 | -7,777 | 159,572 | |||||
| 2015-01-05 | 2015-01-02 | 4 | TAKEYA RYAN K | CLDN | Common Stock | D | 19.8800 | -7,777 | -155 | 1,432 | ||||
| 2015-01-05 | 2015-01-02 | 4 | TAKEYA RYAN K | CLDN | Common Stock | D | 1.1200 | 7,777 | 9 | 9,209 | ||||
| 2015-01-05 | 2015-01-01 | 4 | TAKEYA RYAN K | CLDN | Stock option (right to buy) | D | 19.53 | -72,000 | 167,349 | |||||
| 2015-01-05 | 2015-01-01 | 4 | REED ELIZABETH E | CLDN | Stock option (right to buy) | D | 19.53 | 72,000 | 142,500 | |||||
| 2015-01-05 | 2015-01-01 | 4 | WIKLUND FREDRIK | CLDN | Stock option (right to buy) | D | 19.53 | 80,000 | 193,243 | |||||
| 2015-01-05 | 2015-01-01 | 4 | LABA REBECQUE J | CLDN | Stock option (right to buy) | D | 19.53 | -80,000 | 209,738 | |||||
| 2015-01-05 | 2015-01-01 | 4 | ZSEBO KRISZTINA M | CLDN | Stock option (right to buy) | D | 19.53 | -275,000 | 830,812 | |||||
| 2015-01-05 | 2015-01-01 | 4 | Cleveland Paul B | CLDN | Stock option (right to buy) | D | 19.53 | 140,000 | 417,500 | |||||
| 2015-01-05 | 2015-01-01 | 4 | RUDY JEFFREY J | CLDN | Stock option (right to buy) | D | 19.53 | -80,000 | 191,738 | |||||
| 2014-12-10 | 2014-12-09 | 4 | RUDY JEFFREY J | CLDN | Stock option (right to buy) | D | 1.12 | -10,000 | 111,738 | |||||
| 2014-12-10 | 2014-12-09 | 4 | RUDY JEFFREY J | CLDN | Common Stock | D | 15.0000 | -10,000 | -150 | 414 | ||||
| 2014-12-10 | 2014-12-09 | 4 | RUDY JEFFREY J | CLDN | Common Stock | D | 1.1200 | 10,000 | 11 | 10,414 | ||||
| 2014-12-10 | 2014-12-09 | 4 | ZSEBO KRISZTINA M | CLDN | Stock option (right to buy) | D | 1.12 | -41,302 | 555,812 | |||||
| 2014-12-10 | 2014-12-09 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 15.0000 | -41,302 | -620 | 1,531 | ||||
| 2014-12-10 | 2014-12-09 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 1.1200 | 41,302 | 46 | 42,833 | ||||
| 2014-12-08 | 2014-12-05 | 4 | LABA REBECQUE J | CLDN | Stock option (right to buy) | D | 1.12 | -20,000 | 129,738 | |||||
| 2014-12-08 | 2014-12-05 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 12.7700 | -20,000 | -255 | 691 | ||||
| 2014-12-08 | 2014-12-05 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 1.1200 | 20,000 | 22 | 20,691 | ||||
| 2014-12-02 | 2014-12-01 | 4 | TAKEYA RYAN K | CLDN | Stock option (right to buy) | D | 1.12 | -7,777 | 95,349 | |||||
| 2014-12-02 | 2014-12-01 | 4 | TAKEYA RYAN K | CLDN | Common Stock | D | 12.0100 | -7,777 | -93 | 577 | ||||
| 2014-12-02 | 2014-12-01 | 4 | TAKEYA RYAN K | CLDN | Common Stock | D | 1.1200 | 7,777 | 9 | 8,354 | ||||
| 2014-11-18 | 2014-11-14 | 4 | RUDY JEFFREY J | CLDN | Stock option (right to buy) | D | 1.12 | -18,000 | 121,738 | |||||
| 2014-11-18 | 2014-11-14 | 4 | RUDY JEFFREY J | CLDN | Common Stock | D | 11.6700 | -18,000 | -210 | 0 | ||||
| 2014-11-18 | 2014-11-14 | 4 | RUDY JEFFREY J | CLDN | Common Stock | D | 1.1200 | 18,000 | 20 | 18,000 | ||||
| 2014-06-20 | 3 | Cleveland Paul B | CLDN | No securities are beneficially owned | D | 0 | ||||||||
| 2014-06-20 | 2014-06-19 | 4 | Cleveland Paul B | CLDN | Stock option (right to buy) | D | 14.40 | 277,500 | 277,500 | |||||
| 2014-06-11 | 2014-06-09 | 4 | REED ELIZABETH E | CLDN | Stock option (right to buy) | D | 9.12 | 65,000 | 65,000 | |||||
| 2014-05-29 | 2014-05-28 | 4 | WIKLUND FREDRIK | CLDN | Stock option (right to buy) | D | 9.26 | 10,000 | 10,000 | |||||
| 2014-05-21 | 2014-05-20 | 4 | Yang Patrick Y | CLDN | Stock option (right to buy) | D | 9.58 | 10,000 | 10,000 | |||||
| 2014-05-21 | 2014-05-20 | 4 | Alton Gregg H | CLDN | Stock option (right to buy) | D | 9.58 | 10,000 | 10,000 | |||||
| 2014-05-21 | 2014-05-20 | 4 | NARACHI MICHAEL | CLDN | Stock option (right to buy) | D | 9.58 | 10,000 | 10,000 | |||||
| 2014-05-21 | 2014-05-20 | 4 | COOPER GRAHAM K | CLDN | Stock option (right to buy) | D | 9.58 | 10,000 | 10,000 | |||||
| 2014-05-21 | 2014-05-20 | 4 | Honig Peter | CLDN | Stock option (right to buy) | D | 9.58 | 10,000 | 10,000 | |||||
| 2014-05-21 | 2014-05-20 | 4 | Funder Joshua | CLDN | Stock option (right to buy) | D | 9.58 | 10,000 | 10,000 | |||||
| 2014-03-20 | 2014-03-19 | 4 | LABA REBECQUE J | CLDN | Stock Option (Right to Buy) | D | 12.58 | 10,000 | 10,000 | |||||
| 2014-03-04 | 3 | Yang Patrick Y | CLDN | No securities are beneficially owned. | D | 0 | ||||||||
| 2014-03-04 | 2014-03-02 | 4 | Yang Patrick Y | CLDN | Stock option (right to buy) | D | 11.30 | 2,500 | 2,500 | |||||
| 2014-03-04 | 2014-03-02 | 4 | Yang Patrick Y | CLDN | Stock option (right to buy) | D | 11.30 | 10,000 | 10,000 | |||||
| 2014-03-04 | 3 | Honig Peter | CLDN | No securities are beneficially owned. | D | 0 | ||||||||
| 2014-03-04 | 2014-03-02 | 4 | Honig Peter | CLDN | Stock option (right to buy) | D | 11.30 | 2,500 | 2,500 | |||||
| 2014-03-04 | 2014-03-02 | 4 | Honig Peter | CLDN | Stock option (right to buy) | D | 11.30 | 10,000 | 10,000 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Novartis Bioventures Ltd | CLDN | Common Warrants | D | 5.61 | 25,481 | 25,481 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Novartis Bioventures Ltd | CLDN | Series A-1 Preferred Warrants | D | 0.45 | -318,266 | 0 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Novartis Bioventures Ltd | CLDN | Convertible Promissory Notes | D | 8.00 | 8.0000 | -16,537 | -132 | 0 | |||
| 2014-02-06 | 2014-02-04 | 4 | Novartis Bioventures Ltd | CLDN | Series A-1 Convertible Preferred Stock | D | -17,146,250 | 0 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Novartis Bioventures Ltd | CLDN | Common Stock | D | 8.0000 | 162,386 | 1,299 | 1,551,721 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Novartis Bioventures Ltd | CLDN | Common Stock | D | 8.0000 | 16,537 | 132 | 1,389,335 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Novartis Bioventures Ltd | CLDN | Common Stock | D | 1,372,798 | 1,372,798 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | NARACHI MICHAEL | CLDN | Common Stock | D | 8.0000 | 62,500 | 500 | 62,500 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Foley Todd | CLDN | Warrant to Purchase Common Stock-Right to Buy | I | 5.61 | 17,517 | 17,517 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Foley Todd | CLDN | Warrant to Purchase Series A-1 Preferred Stock-Right to Buy | I | 0.45 | -218,806 | 0 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Foley Todd | CLDN | Convertible Promissory Notes | I | 8.00 | 8.0000 | -11,370 | -91 | 0 | |||
| 2014-02-06 | 2014-02-04 | 4 | Foley Todd | CLDN | Series A-1 Convertible Preferred Stock | I | -11,788,047 | 0 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Foley Todd | CLDN | Common Stock | I | 8.0000 | 111,608 | 893 | 1,066,775 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Foley Todd | CLDN | Common Stock | I | 8.0000 | 11,370 | 91 | 955,167 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Foley Todd | CLDN | Common Stock | I | 943,797 | 943,797 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Enterprise Partners Management LLC By entities affiliated with Enterprise Partners | CLDN | Common Warrants | I | 5.61 | 20,833 | 20,833 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Enterprise Partners Management LLC By entities affiliated with Enterprise Partners | CLDN | Series A-1 Preferred Warrants | I | 0.45 | -260,859 | 0 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Enterprise Partners Management LLC By entities affiliated with Enterprise Partners | CLDN | Convertible Promissory Notes | I | 8.00 | 8.0000 | -13,553 | -108 | 0 | |||
| 2014-02-06 | 2014-02-04 | 4 | Enterprise Partners Management LLC By entities affiliated with Enterprise Partners | CLDN | Junior Preferred Stock | I | -5,741,267 | 0 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Enterprise Partners Management LLC By entities affiliated with Enterprise Partners | CLDN | Series A-1 Convertible Preferred Stock | I | -11,573,520 | 0 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Enterprise Partners Management LLC By entities affiliated with Enterprise Partners | CLDN | Common Stock | I | 8.0000 | 133,083 | 1,065 | 1,950,184 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Enterprise Partners Management LLC By entities affiliated with Enterprise Partners | CLDN | Common Stock | I | 8.0000 | 13,553 | 108 | 1,817,101 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Enterprise Partners Management LLC By entities affiliated with Enterprise Partne | CLDN | Common Stock | I | 459,668 | 1,803,548 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Enterprise Partners Management LLC By entities affiliated with Enterprise Partners | CLDN | Common Stock | I | 926,621 | 1,343,880 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | WIKLUND FREDRIK | CLDN | Common Stock | D | 8.0000 | 20,000 | 160 | 20,000 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Kordel Johan Lundbeckfond Invest A/S | CLDN | Common Warrants | I | 5.61 | 28,666 | 28,666 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Kordel Johan Lundbeckfond Invest A/S | CLDN | Series A-1 Preferred Warrants | I | 0.45 | -358,049 | 0 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Kordel Johan Lundbeckfond Invest A/S | CLDN | Convertible Promissory Notes | I | 8.00 | 8.0000 | -18,605 | -149 | 0 | |||
| 2014-02-06 | 2014-02-04 | 4 | Kordel Johan Lundbeckfond Invest A/S | CLDN | Series A-1 Convertible Preferred Stock | I | -19,289,531 | 0 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Kordel Johan Lundbeckfond Invest A/S | CLDN | Common Stock | I | 8.0000 | 182,681 | 1,461 | 1,745,683 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Kordel Johan Lundbeckfond Invest A/S | CLDN | Common Stock | I | 8.0000 | 18,605 | 149 | 1,563,002 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Kordel Johan Lundbeckfond Invest A/S | CLDN | Common Stock | I | 1,544,397 | 1,544,397 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Lundbeckfond Invest A/S | CLDN | Common Warrants | D | 5.61 | 28,666 | 28,666 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Lundbeckfond Invest A/S | CLDN | Series A-1 Preferred Warrants | D | 0.45 | -358,049 | 0 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Lundbeckfond Invest A/S | CLDN | Convertible Promissory Notes | D | 8.00 | 8.0000 | -18,605 | -149 | 0 | |||
| 2014-02-06 | 2014-02-04 | 4 | Lundbeckfond Invest A/S | CLDN | Series A-1 Convertible Preferred Stock | D | -19,289,531 | 0 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Lundbeckfond Invest A/S | CLDN | Common Stock | D | 8.0000 | 182,681 | 1,461 | 1,745,683 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Lundbeckfond Invest A/S | CLDN | Common Stock | D | 8.0000 | 18,605 | 149 | 1,563,002 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Lundbeckfond Invest A/S | CLDN | Common Stock | D | 1,544,397 | 1,544,397 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Funder Joshua GBS Bioventures IV | CLDN | Common Warrants | I | 5.61 | 53,807 | 53,807 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Funder Joshua GBS Bioventures IV | CLDN | Series A-1 Preferred Warrants | I | 0.45 | -672,060 | 0 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Funder Joshua GBS Bioventures IV | CLDN | Convertible Promissory Notes | I | 8.00 | 8.0000 | -23,145 | -185 | 0 | |||
| 2014-02-06 | 2014-02-04 | 4 | Funder Joshua GBS Bioventures IV | CLDN | Series A-1 Convertible Preferred Stock | I | -11,788,047 | 0 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Funder Joshua GBS Bioventures IV | CLDN | Common Stock | I | 8.0000 | 227,261 | 1,818 | 1,194,204 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Funder Joshua GBS Bioventures IV | CLDN | Common Stock | I | 8.0000 | 23,145 | 185 | 966,943 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Funder Joshua GBS Bioventures IV | CLDN | Common Stock | I | 943,798 | 943,798 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | PFIZER INC | CLDN | Common Warrants | D | 5.61 | 42,659 | 42,659 | |||||
| 2014-02-06 | 2014-02-04 | 4 | PFIZER INC | CLDN | Series A-1 Preferred Warrants | D | 0.45 | -532,818 | 0 | |||||
| 2014-02-06 | 2014-02-04 | 4 | PFIZER INC | CLDN | Convertible Promissory Notes | D | 8.00 | 8.0000 | -23,145 | -185 | 0 | |||
| 2014-02-06 | 2014-02-04 | 4 | PFIZER INC | CLDN | Series A-1 Convertible Preferred Stock | D | -19,289,531 | 0 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | PFIZER INC | CLDN | Common Stock | D | 8.0000 | 227,261 | 1,818 | 1,794,803 | ||||
| 2014-02-06 | 2014-02-04 | 4 | PFIZER INC | CLDN | Common Stock | D | 8.0000 | 23,145 | 185 | 1,567,542 | ||||
| 2014-02-06 | 2014-02-04 | 4 | PFIZER INC | CLDN | Common Stock | D | 1,544,397 | 1,544,397 | ||||||
| 2014-01-29 | 3 | Enterprise Partners Liquidating Trust VI By entities affiliated with Enterprise Partners | CLDN | Common Stock | I | 417,259 |
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)
